Group One Trading’s Lunai Bioworks LNAI Stock Holding History

Group One Trading’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.92K	Buy	1,200 +1,050	+700%	+$2.89K	﹤0.01%	6826
2026 Q1	$489	Buy	+150	New	+$745	﹤0.01%	7322
2024 Q3	–	Sell	-25	Closed	-$3.5K	–	7249
2024 Q2	$3.5K	Sell	25 -239	-91%	-$32.6K	﹤0.01%	6087
2024 Q1	$55.9K	Buy	264 +120	+83%	+$32.4K	﹤0.01%	4630
2023 Q4	$36.5K	Sell	144 -216	-60%	-$59.2K	﹤0.01%	5309
2023 Q3	$129K	Buy	+360	New	+$54.7K	﹤0.01%	4216
2022 Q4	–	Sell	-25	Closed	-$4K	–	7953
2022 Q3	$4K	Sell	25 -94	-79%	-$17.1K	﹤0.01%	6950
2022 Q2	$18K	Buy	119 +34	+40%	+$15.6K	﹤0.01%	6370
2022 Q1	$56K	Buy	85 +71	+507%	+$37.8K	﹤0.01%	6008
2021 Q4	$8K	Buy	+14	New	+$10.2K	﹤0.01%	7470

Other funds holding LNAI

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's LNAI Position: Q2 2026 in Review

Group One Trading reduced its Lunai Bioworks (LNAI) stake by 0.18% in Q2 2026, selling an estimated $3 and leaving 544 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #7061.

Group One Trading first reported a position in LNAI in Q3 2021 and has held it in 9 quarters since. The position peaked at $14K in Q4 2021. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

Group One Trading held 544 shares of Lunai Bioworks worth $1.78K as of Q2 2026.
Group One Trading sold 1 Lunai Bioworks share in Q2 2026, an estimated $3.
Lunai Bioworks made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7061 holding.
Group One Trading first reported a position in Lunai Bioworks in Q3 2021 and has held it in 9 quarters since.
Group One Trading's Lunai Bioworks position peaked at $14K in Q4 2021.
15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.